- Home
- PESI vs TARA Comparison
PESI vs TARA Comparison
Compare PESI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- TARA
- Stock Information
- Founded
- PESI 1990
- TARA N/A
- Country
- PESI United States
- TARA United States
- Employees
- PESI N/A
- TARA N/A
- Industry
- PESI Environmental Services
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PESI Industrials
- TARA Health Care
- Exchange
- PESI Nasdaq
- TARA Nasdaq
- Market Cap
- PESI 205.4M
- TARA 220.7M
- IPO Year
- PESI 1992
- TARA N/A
- Fundamental
- Price
- PESI $13.93
- TARA $5.10
- Analyst Decision
- PESI
- TARA Strong Buy
- Analyst Count
- PESI 0
- TARA 6
- Target Price
- PESI N/A
- TARA $19.80
- AVG Volume (30 Days)
- PESI 202.3K
- TARA 521.2K
- Earning Date
- PESI 11-12-2025
- TARA 11-11-2025
- Dividend Yield
- PESI N/A
- TARA N/A
- EPS Growth
- PESI N/A
- TARA N/A
- EPS
- PESI N/A
- TARA N/A
- Revenue
- PESI $60,019,000.00
- TARA N/A
- Revenue This Year
- PESI $8.35
- TARA N/A
- Revenue Next Year
- PESI $82.81
- TARA N/A
- P/E Ratio
- PESI N/A
- TARA N/A
- Revenue Growth
- PESI N/A
- TARA N/A
- 52 Week Low
- PESI $6.25
- TARA $1.80
- 52 Week High
- PESI $16.25
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- PESI 72.45
- TARA 57.07
- Support Level
- PESI $13.50
- TARA $4.96
- Resistance Level
- PESI $14.17
- TARA $5.92
- Average True Range (ATR)
- PESI 0.72
- TARA 0.35
- MACD
- PESI 0.39
- TARA -0.08
- Stochastic Oscillator
- PESI 88.15
- TARA 24.32
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).